HCA Healthcare, Inc.
NYSE:HCA · New York Stock Exchange
-$12.05 today
Vol 2.63M · Avg 1.37M
Cash Flow
Check whether earnings turn into cash
Use operating cash flow, capital spending, free cash flow, and financing activity to see how much value is left for reinvestment or owners.
Free Cash Flow
Net Income to FCF bridge
Analysis
Analysis will appear once cash flow data is available for this period.
Cash Flow Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net Income | $6.8B +1.9% | $6.7B +27.0% | $5.2B -23.3% | $6.8B -11.5% | $7.7B | $487.6M | $476.4M | $465.2M |
| Depreciation & Amortization | $3.5B +6.4% | $3.3B +7.6% | $3.1B +3.6% | $3.0B +4.1% | $2.9B | $374.2M | $1.2B | $631.8M |
| Deferred Income Tax | $0 -100.0% | $22.0M -90.4% | $229.0M -59.9% | $571.0M +915.7% | -$70.0M | $1.4B | -$1.5B | $304.2M |
| Stock-Based Compensation | $0 -100.0% | $360.0M | $0 -100.0% | $341.0M -22.5% | $440.0M | $489.0M | $354.6M | -$1.6B |
| Change in Working Capital | $728.0M +786.8% | -$106.0M +76.8% | -$457.0M +60.3% | -$1.2B -129.0% | -$503.0M | $350.4M | -$1.6B | $1.5B |
| Accounts Receivables | -$94.0M +88.2% | -$799.0M +14.5% | -$935.0M -17.3% | -$797.0M +17.2% | -$962.0M | $592.6M | $1.3B | $626.2M |
| Inventory | -$154.0M -146.1% | $334.0M +365.1% | -$126.0M -113.6% | -$59.0M +89.1% | -$540.0M | $1.0B | $1.2B | $1.1B |
| Accounts Payables | $666.0M +85.5% | $359.0M -40.6% | $604.0M +304.1% | -$296.0M -129.6% | $999.0M | $948.2M | -$1.5B | $433.0M |
| Other Working Capital | $310.0M | $0 | $0 | $0 | $0 | $567.4M | $1.3B | $601.0M |
| Other Non-Cash Items | $1.6B +495.2% | $269.0M -79.9% | $1.3B +228.7% | -$1.0B +29.8% | -$1.5B | $1.4B | -$1.5B | $300.0M |
| Operating Cash Flow | $12.6B +20.2% | $10.5B +11.5% | $9.4B +10.7% | $8.5B -4.9% | $9.0B | $7.2B | $8.9B | $10.5B |
| Capital Expenditures | -$4.9B -1.4% | -$4.9B -2.8% | -$4.7B -7.9% | -$4.4B -22.9% | -$3.6B | $664.0M | $1.4B | $697.6M |
| Acquisitions (Net) | -$128.0M -306.5% | $62.0M +114.0% | -$442.0M -143.6% | $1.0B -4.0% | $1.1B | $937.0M | $1.1B | $1.3B |
| Purchases of Investments | $0 | $0 | $0 +100.0% | -$14.0M +88.0% | -$117.0M | $444.2M | $1.4B | $1.3B |
| Sales of Investments | $72.0M | $0 | $0 -100.0% | $14.0M -88.0% | $117.0M | $822.2M | $318.2M | -$1.5B |
| Other Investing Activities | $12.0M +110.0% | -$120.0M +8.4% | -$131.0M -1771.4% | -$7.0M +94.2% | -$121.0M | $616.4M | $370.0M | $1.2B |
| Investing Cash Flow | -$5.0B -1.1% | -$4.9B +7.2% | -$5.3B -56.9% | -$3.4B -28.2% | -$2.6B | $4.8B | $6.4B | $5.1B |
| Debt Repayment | $3.2B +0.1% | $3.2B +147.5% | $1.3B -60.6% | $3.3B +1.0% | $3.3B | $680.8M | $759.2M | $1.1B |
| Common Stock Issued | $0 | $0 | $0 | $0 | $0 | $778.8M | $946.8M | $812.4M |
| Common Stock Repurchased | -$10.1B -66.6% | -$6.0B -58.5% | -$3.8B +45.6% | -$7.0B +14.8% | -$8.2B | $351.8M | -$1.6B | $1.5B |
| Dividends Paid | -$679.0M +1.6% | -$690.0M -4.4% | -$661.0M -1.2% | -$653.0M -4.6% | -$624.0M | $535.2M | $613.6M | $692.0M |
| Other Financing Activities | -$1.0B +4.1% | -$1.1B -15.0% | -$917.0M +28.9% | -$1.3B -20.4% | -$1.1B | -$1.6B | $1.3B | $1.1B |
| Financing Cash Flow | -$8.6B -86.6% | -$4.6B -11.9% | -$4.1B +27.6% | -$5.7B +15.0% | -$6.7B | $12.2B | $13.9B | -$15.5B |
| Effect of Forex Changes | $9.0M +1000.0% | -$1.0M -114.3% | $7.0M +135.0% | -$20.0M -566.7% | -$3.0M | $1.3B | $1.1B | $990.2M |
| Net Change in Cash | -$893.0M -189.5% | $998.0M +3596.3% | $27.0M +105.0% | -$543.0M -58.8% | -$342.0M | $3.2B | $4.9B | $6.5B |
| Free Cash Flow | $7.7B +36.4% | $5.6B +20.3% | $4.7B +13.6% | $4.1B -23.3% | $5.4B | $8.6B | -$16.8B | $11.1B |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Pfizer Inc.
NYSE:PFE
$143.91B
CVS Health Corporation
NYSE:CVS
$125.53B
Stryker Corporation
NYSE:SYK
$119.17B
Vertex Pharmaceuticals Incorporated
NASDAQ:VRTX
$114.84B
Bristol-Myers Squibb Company
NYSE:BMY
$110.06B
GSK plc
NYSE:GSK
$101.88B
Sanofi
NASDAQ:SNY
$101.47B
Medtronic plc
NYSE:MDT
$101.45B
McKesson Corporation
NYSE:MCK
$87.79B
Tenet Healthcare Corporation
NYSE:THC
$14.90B
SEC Filings
Recent regulatory filings
No filings found.
Does HCA generate free cash flow?
HCA Healthcare, Inc. (HCA) generated $7.69B of free cash flow in fiscal 2025.
How much operating cash flow does HCA produce?
Operating cash flow was $12.64B, before capital expenditures of $4.94B.
Explore More
Continue the stock analysis
Jump to another research area for this company.